Cargando…

Cerebral embolic protection and severity of stroke following transcatheter aortic valve replacement

BACKGROUND: The cerebral embolic protection (CEP) device captures embolic debris during transcatheter aortic valve replacement (TAVR). However, the impact of CEP on stroke severity following TAVR remains unclear. Therefore, we aimed to examine whether CEP was associated with reduced severity of stro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Isogai, Toshiaki, Vanguru, Husitha Reddy, Krishnaswamy, Amar, Agrawal, Ankit, Spilias, Nikolaos, Shekhar, Shashank, Saad, Anas M., Verma, Beni Rai, Puri, Rishi, Reed, Grant W., Popović, Zoran B., Unai, Shinya, Yun, James J., Uchino, Ken, Kapadia, Samir R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Valvular and Structural Heart Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805232/ https://www.ncbi.nlm.nih.gov/pubmed/35916117 http://dx.doi.org/10.1002/ccd.30340

Ejemplares similares

Association between haematological parameters and outcomes following transcatheter aortic valve implantation at mid-term follow-up
por: Abushouk, Abdelrahman, et al.
Publicado: (2022)

Comparison of Outcomes Following Transcatheter Aortic Valve Replacement Requiring Peripheral Vascular Intervention or Alternative Access
por: Isogai, Toshiaki, et al.
Publicado: (2023)

Single center TAVR experience with a focus on the prevention and management of catastrophic complications
por: Kapadia, Samir R, et al.
Publicado: (2014)

Predictors of Procedural Success in Patients With Degenerated Surgical Valves Undergoing Transcatheter Aortic Valve-in-Valve Implantation
por: Abushouk, Abdelrahman I., et al.
Publicado: (2021)

Clinical risk model for predicting 1‐year mortality after transcatheter aortic valve replacement
por: Yamamoto, Masanori, et al.
Publicado: (2020)

Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
por: Goldsweig, Andrew M., et al.
Publicado: (2022)

Transcatheter mitral valve repair in a high‐surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly™ Transcatheter Repair device—First in man implantation in China
por: Liu, Xianbao, et al.
Publicado: (2021)

One‐year clinical outcome with a novel self‐expanding transcatheter heart valve
por: Pellegrini, Costanza, et al.
Publicado: (2019)

Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome
por: Meijerink, Frank, et al.
Publicado: (2021)

Transcatheter aortic valve implantation with the novel‐generation Navitor device: Procedural and early outcomes
por: Corcione, Nicola, et al.
Publicado: (2022)

Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation
por: Asami, Masahiko, et al.
Publicado: (2022)

Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex
por: Yong, Celina M., et al.
Publicado: (2022)

Right atrial structural remodeling predict worse outcomes in transcatheter mitral valve repair
por: Miller, Matthew S., et al.
Publicado: (2022)

Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

SAPIEN 3 transcatheter heart valve in patients with borderline annulus: “stretched better than bigger?”
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program
por: Hokken, Thijmen W., et al.
Publicado: (2021)

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve
por: Liu, Xianbao, et al.
Publicado: (2018)

Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry
por: Moriyama, Noriaki, et al.
Publicado: (2020)

The impact of frailty on adverse outcomes after transcatheter aortic valve replacement in older adults: A retrospective cohort study
por: Dautzenberg, Lauren, et al.
Publicado: (2022)

A comparison of valve‐in‐valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves
por: Choi, Charles H., et al.
Publicado: (2018)

Vascular complications with a plug‐based vascular closure device after transcatheter aortic valve replacement: Predictors and bail‐outs
por: van Wiechen, Maarten P., et al.
Publicado: (2021)

Uninterrupted vitamin K antagonists in patients undergoing transcatheter aortic valve implantation: A promising strategy still looking for the right patient
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Novel oral anticoagulants versus vitamin K antagonists in transcatheter aortic valve replacement treated patients—Patients' vulnerability still matters
por: Tarantini, Giuseppe, et al.
Publicado: (2022)

Long term follow‐up after balloon expandable covered stents implantation for management of transcatheter aortic valve replacement related vascular access complications
por: Maurina, Matteo, et al.
Publicado: (2022)

Trends, predictors, and outcomes of transcatheter aortic valve implantation in patients with bicuspid aortic valve related disease: Insights from the Nationwide Inpatient Sample and Nationwide Readmission Database
por: Ullah, Waqas, et al.
Publicado: (2022)

Development and validation of a prediction model for early mortality after transcatheter aortic valve implantation (TAVI) based on the Netherlands Heart Registration (NHR): The TAVI‐NHR risk model
por: Al‐Farra, Hatem, et al.
Publicado: (2022)

Risk Stratification and Management of Advanced Conduction Disturbances Following TAVI in Patients With Pre-Existing RBBB
por: Isogai, Toshiaki, et al.
Publicado: (2022)

Indocyanine green clearance predicts outcome in patients undergoing transcatheter valve intervention for severe atrio-ventricular valve regurgitation
por: Doldi, Philipp Maximilian, et al.
Publicado: (2023)

Final 3‐year clinical outcomes following transcatheter aortic valve implantation with a supra‐annular self‐expanding repositionable valve in a real‐world setting: Results from the multicenter FORWARD study
por: Van Mieghem, Nicolas M., et al.
Publicado: (2021)

Clinical, functional and prognostic implications of severe atrial dilation in secondary mitral regurgitation
por: Layoun, Habib, et al.
Publicado: (2022)

Impact of transcatheter aortic valve implantation on mechanical dispersion
por: Klaeboe, Lars Gunnar, et al.
Publicado: (2020)

Evaluation of the 2021 European Society of Cardiology guidelines in pre-existing right bundle branch block patients undergoing transcatheter aortic valve implantation with a balloon-expandable valve
por: Isogai, Toshiaki, et al.
Publicado: (2022)

Mitral and aortic regurgitation following transcatheter aortic valve replacement
por: Szymański, Piotr, et al.
Publicado: (2016)

Predictors of early mortality after transcatheter aortic valve implantation
por: Kjønås, Didrik, et al.
Publicado: (2019)

CT imaging prior to transcatheter aortic valve implantation in the UK
por: Harries, Iwan, et al.
Publicado: (2020)

Transcatheter mitral valve repair: an overview of current and future devices
por: De Backer, Ole, et al.
Publicado: (2021)

Anatomical predictors of conduction damage after transcatheter implantation of the aortic valve
por: Tretter, Justin T, et al.
Publicado: (2019)

Sex differences in patients undergoing transcatheter aortic valve replacement in Asia
por: Chiam, Paul T L, et al.
Publicado: (2021)

Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation
por: Cohen, David J, et al.
Publicado: (2022)

Impact of social deprivation on outcome following transcatheter aortic valve implantation (TAVI)
por: Mohee, Kevin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p2njbtocd69csq5277vhhsc91v